Polycystic Ovary Syndrome and Risks for COVID-19 Infection: A Comprehensive Review
February 2022
in “
Reviews in Endocrine and Metabolic Disorders
”
Studysummary This review reports that women with polycystic ovary syndrome are at 28%–50% higher risk of SARS-CoV-2 infection, with increased rates of COVID-19-related hospitalization, morbidity, and mortality.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →